Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Couch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Biology : CB|November 7, 2002
Axon guidance: Comm hither, RoboJessica Couch, Barry Condron
International Journal of Toxicology|June 24, 2009
Alternative strategies for toxicity testing of species-specific biopharmaceuticalsJeanine L Bussiere, Pauline Martin, Michelle Horner, et al.
Toxicologic Pathology|March 30, 2017
Regulatory Forum Opinion Piece<sup>*</sup>: Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry SurveySherry J Morgan, Jessica Couch, Peggy Guzzie-Peck, et al.
Developmental Neuropsychology|May 14, 2009
Early childhood obesity is associated with compromised cerebellar developmentJennifer L Miller, Jessica Couch, Krista Schwenk, et al.
Mabs|May 6, 2017
Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal useFiona Sewell, Kathryn Chapman, Jessica Couch, et al.
ILAR Journal|January 6, 2017
Balancing Blood Sample Volume with 3Rs: Implementation and Best Practices for Small Molecule Toxicokinetic Assessments in RatsEric Harstad, Roxanne Andaya, Jessica Couch, et al.
Regulatory Toxicology and Pharmacology : RTP|March 26, 2013
Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translationKathryn L Chapman, Henry Holzgrefe, Lauren E Black, et al.
Regulatory Toxicology and Pharmacology : RTP|November 22, 2011
The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primatesKathryn L Chapman, Laura Andrews, Jeffrey J Bajramovic, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 2014
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trialsFiona Sewell, Kathryn Chapman, Paul Baldrick, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Biology : CB|November 7, 2002
Axon guidance: Comm hither, RoboJessica Couch, Barry Condron
International Journal of Toxicology|June 24, 2009
Alternative strategies for toxicity testing of species-specific biopharmaceuticalsJeanine L Bussiere, Pauline Martin, Michelle Horner, et al.
Toxicologic Pathology|March 30, 2017
Regulatory Forum Opinion Piece<sup>*</sup>: Use and Utility of Animal Models of Disease for Nonclinical Safety Assessment: A Pharmaceutical Industry SurveySherry J Morgan, Jessica Couch, Peggy Guzzie-Peck, et al.
Developmental Neuropsychology|May 14, 2009
Early childhood obesity is associated with compromised cerebellar developmentJennifer L Miller, Jessica Couch, Krista Schwenk, et al.
Mabs|May 6, 2017
Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal useFiona Sewell, Kathryn Chapman, Jessica Couch, et al.
ILAR Journal|January 6, 2017
Balancing Blood Sample Volume with 3Rs: Implementation and Best Practices for Small Molecule Toxicokinetic Assessments in RatsEric Harstad, Roxanne Andaya, Jessica Couch, et al.
Regulatory Toxicology and Pharmacology : RTP|March 26, 2013
Pharmaceutical toxicology: designing studies to reduce animal use, while maximizing human translationKathryn L Chapman, Henry Holzgrefe, Lauren E Black, et al.
Regulatory Toxicology and Pharmacology : RTP|November 22, 2011
The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primatesKathryn L Chapman, Laura Andrews, Jeffrey J Bajramovic, et al.
Regulatory Toxicology and Pharmacology : RTP|August 1, 2014
Recommendations from a global cross-company data sharing initiative on the incorporation of recovery phase animals in safety assessment studies to support first-in-human clinical trialsFiona Sewell, Kathryn Chapman, Paul Baldrick, et al.
Pageof 1